Pharm Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 8.00 M
as on 06-07-2024
- Company Age 68 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.97 Cr
as on 06-07-2024
- Satisfied Charges ₹ 48.81 Cr
as on 06-07-2024
- Revenue 5.56%
(FY 2023)
- Profit 126.85%
(FY 2023)
- Ebitda 17.49%
(FY 2023)
- Net Worth 143.08%
(FY 2023)
- Total Assets 74.79%
(FY 2023)
About Pharm Products
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹5.97 Cr. The company has closed loans amounting to ₹48.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
Doraiswamy Rajasekaran, Ravichandran Kala, and Thiagarajan Ravichandran serve as directors at the Company.
- CIN/LLPIN
U24231TN1956PTC003362
- Company No.
003362
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 1956
- Date of AGM
21 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Thanjavur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pharm Products Private Limited offer?
Pharm Products Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, HIV Drugs, Antihistamines, Pharmaceutical Capsules, Cardiac Drugs, Anticoagulant and Antiplatelet Drugs, Cough Syrup, Fitness Clubs and Beauty Parlours, Beauty Services.
Who are the key members and board of directors at Pharm Products?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thiagarajan Ravichandran  | Managing Director | 17-Dec-1987 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Doraiswamy Rajasekaran | Director | 17-Aug-1993 | Current |
| Ravichandran Kala | Whole-Time Director | 08-Apr-1994 | Current |
Financial Performance of Pharm Products.
Pharm Products Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.56% increase. The company also saw a substantial improvement in profitability, with a 126.85% increase in profit. The company's net worth Soared by an impressive increase of 143.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharm Products?
In 2023, Pharm Products had a promoter holding of 96.99% and a public holding of 3.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Jun 2023 | ₹2.30 M | Open |
Canara Bank Creation Date: 27 Dec 1989 | ₹5.74 Cr | Open |
Yes Bank Limited Creation Date: 31 Dec 2018 | ₹0.95 M | Satisfied |
How Many Employees Work at Pharm Products?
Pharm Products has a workforce of 104 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharm Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharm Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
